RTP-based AskBio taps former Histogenics exec as new chief business officer
Don Haut, PhD, who previously served as CBO at Sherlock Biosciences and Histogenics, is taking on the role at the clinical-stage adeno-associated virus (AAV) gene therapy company based in RTP.
Read More
